Takeda Pharmaceutical Co Ltd - Strategy, SWOT and Corporate Finance Report

Takeda Pharmaceutical Co Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company

Key Highlights

Takeda Pharmaceutical Company Ltd (Takeda) is a research-based pharmaceutical company which focuses on the research and development, manufacture, marketing, commercialization and import and export of pharmaceutical drugs and consumer health care products. The company manufactures and markets a wide range of products in therapy areas including gastrointestinal, rare diseases, oncology, neuroscience and plasma-derived therapies. Takeda markets its drugs worldwide through its subsidiaries and has production, and research and development facilities in North America, Europe and Asia. Takeda is headquartered in Chuo-ku, Osaka, Japan.

Scope

  • Detailed information on Takeda Pharmaceutical Co Ltd required for business and competitor intelligence needs
  • A study of the major internal and external factors affecting Takeda Pharmaceutical Co Ltd in the form of a SWOT analysis
  • An in-depth view of the business model of Takeda Pharmaceutical Co Ltd including a breakdown and examination of key business segments
  • News about Takeda Pharmaceutical Co Ltd, such as business expansion, restructuring, and contract wins
  • Large number of easy-to-grasp charts and graphs that present important data and key trends

Reasons to buy

  • Gain understanding of Takeda Pharmaceutical Co Ltd and the factors that influence its strategies.
  • Track strategic initiatives of the company and latest corporate news and actions.
  • Assess Takeda Pharmaceutical Co Ltd as a prospective partner, vendor or supplier.
  • Support sales activities by understanding your customers' businesses better.
  • Stay up to date on Takeda Pharmaceutical Co Ltds business structure, strategy and prospects.

Note: Some sections may be missing if data is unavailable for the company.

Companies mentioned

F. Hoffmann-La Roche Ltd

Janssen Biotech Inc

Novo Nordisk AS

Novartis AG

Celgene Corp

Biotest AG

Pfizer Inc

Grifols SA

Taisho Pharmaceutical Holdings Co Ltd ...

F. Hoffmann-La Roche Ltd

Janssen Biotech Inc

Novo Nordisk AS

Novartis AG

Celgene Corp

Biotest AG

Pfizer Inc

Grifols SA

Taisho Pharmaceutical Holdings Co Ltd

Bayer AG

AstraZeneca Plc

Amgen Inc

Sumitomo Chemical Co Ltd

Merck & Co Inc

Bristol-Myers Squibb Co

Johnson & Johnson

Octapharma AG

AbbVie Inc

Table of Contents

Table of Contents

Table of Contents

List of Tables

List of Figures

Section 1 - About the Company

Takeda Pharmaceutical Co Ltd - Key Facts ...

Table of Contents

Table of Contents

List of Tables

List of Figures

Section 1 - About the Company

Takeda Pharmaceutical Co Ltd - Key Facts

Takeda Pharmaceutical Co Ltd - Key Employees

Takeda Pharmaceutical Co Ltd - Key Employee Biographies

Takeda Pharmaceutical Co Ltd - Major Products and Services

Takeda Pharmaceutical Co Ltd - History

Takeda Pharmaceutical Co Ltd - Company Statement

Takeda Pharmaceutical Co Ltd - Locations And Subsidiaries

Head Office

Other Locations & Subsidiaries

Joint Venture

Section 2 – Company Analysis

Company Overview

Takeda Pharmaceutical Co Ltd - Business Description

Business Segment: Pharmaceutical Products

Overview

Geographical Segment: Asia

Performance

Geographical Segment: Europe and Canada

Performance

Geographical Segment: Japan

Performance

Geographical Segment: Latin America

Performance

Geographical Segment: Other

Performance

Geographical Segment: Russia/CIS

Performance

Geographical Segment: United States

Performance

R&D Overview

Takeda Pharmaceutical Co Ltd - Corporate Strategy

Takeda Pharmaceutical Co Ltd - SWOT Analysis

SWOT Analysis - Overview

Takeda Pharmaceutical Co Ltd - Strengths

Takeda Pharmaceutical Co Ltd - Weaknesses

Takeda Pharmaceutical Co Ltd - Opportunities

Takeda Pharmaceutical Co Ltd - Threats

Takeda Pharmaceutical Co Ltd - Key Competitors

Section 3 – Company Financial Ratios

Financial Ratios - Capital Market Ratios

Financial Ratios - Annual Ratios

Performance Chart

Financial Performance

Financial Ratios - Interim Ratios

Financial Ratios - Ratio Charts

Section 4 – Company’s Lifesciences Financial Deals and Alliances

Takeda Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2013 to YTD 2019

Takeda Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals By Type, 2013 to YTD 2019

Takeda Pharmaceutical Co Ltd, Recent Deals Summary

Section 5 – Company’s Recent Developments

Jul 09, 2019: Takeda continues ongoing inclusion in the FTSE4Good Developed Index & MSCI ESG Leaders Index

Jul 03, 2019: Novartis acquires ophthalmic drug from Takeda for $3.4bn

Jul 03, 2019: Takeda to demonstrate global leadership in hematology at ISTH 2019

Jun 26, 2019: Takeda selects five new partnerships for annual global Corporate Social Responsibility (CSR) Program, Supporting Disease Prevention to Improve Health in Developing and Emerging Countries New Partnerships for Annual Global Corporate Social Responsibility (CSR) Program, supporting disease prevention to improve health in developing and emerging countries

Jun 26, 2019: DNDi receives 1 billion yen from Takeda to improve access to treatment for neglected patients

Jun 04, 2019: Amgen and Takeda join the Quantum Leap project led by CQDM and Feldan Therapeutics, to improve a novel intracellular delivery technology

Jun 02, 2019: Takeda makes first private sector Pledge for Global Fund Replenishment

May 17, 2019: Takeda and Frazier team up to launch biopharmaceutical firm

May 14, 2019: Takeda reports FY2018 full year results and issues FY2019 guidance

May 09, 2019: Takeda to divest dry eye drug to Novartis in $5.3bn deal

Section 6 – Appendix

Methodology

Ratio Definitions

About GlobalData

Contact Us

Disclaimer

List of Tables

List of Tables

Takeda Pharmaceutical Co Ltd, Key Facts

Takeda Pharmaceutical Co Ltd, Key Employees

Takeda Pharmaceutical Co Ltd, Key Employee Biographies

Takeda Pharmaceutical Co ...

List of Tables

Takeda Pharmaceutical Co Ltd, Key Facts

Takeda Pharmaceutical Co Ltd, Key Employees

Takeda Pharmaceutical Co Ltd, Key Employee Biographies

Takeda Pharmaceutical Co Ltd, Major Products and Services

Takeda Pharmaceutical Co Ltd, History

Takeda Pharmaceutical Co Ltd, Other Locations

Takeda Pharmaceutical Co Ltd, Subsidiaries

Takeda Pharmaceutical Co Ltd, Joint Venture

Takeda Pharmaceutical Co Ltd, Key Competitors

Takeda Pharmaceutical Co Ltd, Ratios based on current share price

Takeda Pharmaceutical Co Ltd, Annual Ratios

Takeda Pharmaceutical Co Ltd, Annual Ratios (Cont...1)

Takeda Pharmaceutical Co Ltd, Annual Ratios (Cont...2)

Takeda Pharmaceutical Co Ltd, Interim Ratios

Takeda Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2013 to YTD 2019

Takeda Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals By Type, 2013 to YTD 2019

Takeda Pharmaceutical Co Ltd, Recent Deals Summary

Currency Codes

Capital Market Ratios

Equity Ratios

Profitability Ratios

Cost Ratios

Liquidity Ratios

Leverage Ratios

Efficiency Ratios

List of Figures

List of Figures

Takeda Pharmaceutical Co Ltd, Performance Chart (2015 - 2019)

Takeda Pharmaceutical Co Ltd, Ratio Charts

Takeda Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, ...

List of Figures

Takeda Pharmaceutical Co Ltd, Performance Chart (2015 - 2019)

Takeda Pharmaceutical Co Ltd, Ratio Charts

Takeda Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2013 to YTD 2019

Takeda Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2013 to YTD 2019

    Pricing

Discounts available for multiple report purchases.

reportstore@marketline.com
+44 (0) 161 359 5817

Saved reports